Hou Y, Ernst SA, Heidenreich K, and Williams JA
Beyond just lowering your blood sugar, GLP-1 drugs affect the entire gastrointestinal system and even the brain to produce weight loss
GLP-1 agonists are FDA-labeled for BMI 30+ or BMI 27+ with weight-related comorbidities, but clinical candidacy depends on individual metabolic factors
1 Muscle mass often decreases, lowering resting metabolic rate
This scientifically backed supplement has been shown in studies to promote muscle, tendons, ligaments, gut, and bone healing (Seiwerth et al, 2018)
The same analysis also notes that approximately 15% of users experienced vomiting after microdosing Tirzepatide, which highlights that attempting lower or unconventional dosing does not eliminate acute adverse effects and may introduce its own pattern of harms